Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis

Author： George S.J.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.5, 2000-05, pp. : 993-1007

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Design, Structure, and Therapeutic Application of Matrix Metalloproteinase Inhibitors

By  

Current Medicinal Chemistry, Vol. 8, Iss. 4, 2001-03 ,pp. : 425-474

Bentham Science Publishers

Access to resources Recommend Favorite

The Clinical Potential of Matrix Metalloproteinase Inhibitors in the Rheumatic Disorders

By Elliott S.   Cawston T.  

Drugs & Aging, Vol. 18, Iss. 2, 2001-02 ,pp. : 87-99

Adis International

Access to resources Recommend Favorite

Curcumin: a potential candidate for matrix metalloproteinase inhibitors

By Kumar Dileep   Kumar Manish   Saravanan Chinnadurai   Singh Sushil Kumar  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 10, 2012-10 ,pp. : 959-972

Informa Healthcare

Access to resources Recommend Favorite

Matrix Metalloproteinase Inhibitors: A Critical Appraisal of Design Principles and Proposed Therapeutic Utility

By Dormán György  

Drugs, Vol. 70, Iss. 8, 2010-05 ,pp. : 949-964

Adis International

Access to resources Recommend Favorite

Matrix Metalloproteinase Knockout Studies and the Potential Use of Matrix Metalloproteinase Inhibitors in the Rheumatic Diseases

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 363-375

Bentham Science Publishers

Access to resources Recommend Favorite